Healthcare
RDCP gears up to launch second fund
RDCP Healthcare Opportunities Fund II will target ТЃ50m, to deploy in healthcare assets
Penta-backed Sensiblu buys Belladonna
Belladonna had 93 pharmacies prior to the trasnaction and the divested subsidiary includes 46
Permira-backed Corin boosts US presence with Omni bolt-on
Omni, which makes robotics-assisted medial equipment, is Corin's second bolt-on under Permira
Gilde Healthcare closes third fund on €200m
Gilde Healthcare Services III targets healthcare providers based in the Benelux and DACH regions
Towerbrook's ICS secures refinancing package
Transaction comes almost five years after the GP acquired the business in an SBO from Blackstone
Seventure holds first close for Health for Life II
Investments can range from between €500,000-10m per round, or up to €20m per company
Pureos Bioventures leads CHF 10m series-A for NovaGo
Swiss clinical-stage biotech company Neurimmune also takes part in the investment
Segulah sells CCS to trade
Segulah supported several bolt-on acquisitions and also made partial divestments
Redmile Group invests in Hookipa's €33.2m series-D
Hookipa's previous investors include Sofinnova Partners, Takeda Ventures and Forbion
Syncona leads CHF 35m series-A for Anaveon
Anaveon initially received seed funding from the UZH Life Sciences Fund and BaseLaunch
IK's Colisée bolts on Armonea Group
Combined group could generate revenues of €1bn and host 26,800 residents
Palamon announces roll-over investment into Ober Scharrer
GP sold Ober Scharrer to Nordic last year, generating a 3.6x return on its original investment
Innova Capital sells Neomedic in €70.5m deal
Sale of obstetrics-focused hospital group brings to an end a seven-year holding period
Ardian sells Citoxlab to trade in €448m deal
Sale price implies a 13.8x pro forma EBITDA multiple, based on Citoxlab’s latest results
HTGF in seed round for 8sense
Beurer Group invested in 2018 and HGTF was joined by Thieme Group and a business angel in the round
US healthcare funds buy Moberg Pharma's OTC business for $155m
Purchase price represents a 14.1x entry multiple for the investors and is 3.3x the groupтs revenues
Sunstone holds €80m first close for fourth life science fund
Sunstone Life Science Ventures Fund IV expects to close on its €150m target by early 2020
CBPE acquires Simbec-Orion
GP acquires the life sciences research firm from Wales Life Sciences Investment Fund
Graphite sells Sk:n to TriSpan after 13-year holding
Deal reportedly values the UK-headquartered skincare clinic operator at around ТЃ35m
VC-backed Sequana Medical sets IPO price range
Offer range of €8.50-9.00 gives the medical equipment maker an implied market cap of around €120m
Foresight leads £2m funding round for Fertility Focus
Foresight, which has ТЃ2.8bn in assets under management, invested from two of its VCTs
Waterland launches new buy-and-build with Rehacon
Waterland plans to realise synergies with portfolio companies Median Kliniken and Schönes Leben
Apax hires new healthcare partner
Marc Benatar joins Apax France as a partner in the healthcare team after a stint at Kharis
US Venture, Andera lead €32m series-B for HighLife
Previous backer Sofinnova Partners and new investor Sectoral Asset Management also take part